CMAC 2010; 12(1) | CMAC

CMAC 2010; 12(1)

Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):4-22
PDF

Central venous access is commonly used in clinical practice for a wide spectrum of procedures, such as hemodialysis, long-term …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):23-30
PDF

Introduction. In the conditions of dramatic rising of antibacterial resistance of gram-negative nosocomial pathogens, carbapenems plays …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):31-40
PDF

This paper reviews general issues of the use of antimicrobial agents in pregnant women. Currently available data on safety of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):41-53
PDF

This study was performed to evaluate a potential of ribavirin for inhibiting Batai virus replication in vitro. Ribavirin manufactured …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):54-56
PDF

At present, primary, secondary, and multiple resistance of H. pylori to antimicrobial agents tends to increase, which significantly …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):57-66
PDF

Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) are one of the most important problems in …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):67-76
PDF

A total of 1375 clinical strains of staphylococci isolated from patients in burn units during the 2002–2008 were tested to detect …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):77-81
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):82-85
PDF